PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same
The present disclosure provides nucleic acid molecules, compositions, and pharmaceutical compositions comprising a pattern recognition receptor (PRR) agonist and a microRNA antagonist and methods treating or preventing cancer in a subject in need thereof, the method comprising administering to the s...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English |
Published |
02.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure provides nucleic acid molecules, compositions, and pharmaceutical compositions comprising a pattern recognition receptor (PRR) agonist and a microRNA antagonist and methods treating or preventing cancer in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the nucleic acid molecules, compositions, and pharmaceutical compositions. |
---|---|
Bibliography: | Application Number: US202017430991 |